Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

Table 1 Cortactin immunohistochemical detection in 91 HCCs

	Cortactin IHC score		P
	0-3	4-6
Cases (n)	43	48
Gender			0.846
Male	33	36
Female	10	12
Mean age (years)^a	52.81 ± 1.74	54.46 ± 1.68	0.667
HBsAg			0.265
(−)	9	15
(+)	34	33
AFP (μg/L)^a	276.79 ± 57.33	319.6 ± 61.57	0.614
Liver cirrhosis			0.523
No	10	14
Yes	33	34
Maximal size (mm)^a	6.64 ± 0.84	7.76 ± 0.66	0.531
Liver capsule integrity			0.054
Complete	34	29
Incomplete	9	19
Tumor nodules (n)			0.084
Single	34	30
Multiple	9	18
Cancer embolus or metastasis			0.000^b
No	40	21
Yes	3	27
Edmondson classification			0.375
I-II	21	19
III-IV	22	29
TNM stage (AJCC/UICC)			0.000^b
I-II	32	15
III-IV	11	33

ISSN: 1477-7819